Residency · Baltimore, MD
Sponsored by University of Maryland Program
TENAYA and LUCERNE: Two-Year Results from the Phase 3 Neovascular Age-Related Macular Degeneration Trials of Faricimab with Treat-and-Extend Dosing in Year 2.
Ophthalmology · 2024 · 192 citations · Jeffrey Willis
Efficacy, durability, and safety of intravitreal faricimab with extended dosing up to every 16 weeks in patients with diabetic macular oedema (YOSEMITE and RHINE): two randomised, double-masked, phase 3 trials.
Lancet (London, England) · 2022 · 396 citations · Jeffrey Willis
Efficacy and Safety of Faricimab for Macular Edema due to Retinal Vein Occlusion: 24-Week Results from the BALATON and COMINO Trials.
Ophthalmology · 2024 · 70 citations · Jeffrey Willis
Performance of ChatGPT in Diagnosis of Corneal Eye Diseases.
Cornea · 2024 · 65 citations · Wuqaas Munir
Nicotinamide and Pyruvate for Neuroenhancement in Open-Angle Glaucoma: A Phase 2 Randomized Clinical Trial.
JAMA ophthalmology · 2022 · 123 citations · George Cioffi
Identifying and preventing fraudulent responses in online public health surveys: Lessons learned during the COVID-19 pandemic.
PLOS global public health · 2023 · 60 citations · Megan Collins
Detecting glaucoma with only OCT: Implications for the clinic, research, screening, and AI development.
Progress in retinal and eye research · 2022 · 80 citations · George Cioffi
Divergent and self-reactive immune responses in the CNS of COVID-19 patients with neurological symptoms.
Cell reports. Medicine · 2021 · 156 citations · Sarah Sunshine